Objective. The objective of this study is to evaluate the cost‐effectiveness of catheter
ablation for rhythm control compared to antiarrhythmic drug (AAD) therapy in patients with …

Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for
Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of …

The use of catheter ablation to treat AF is increasing rapidly, but there is presently an
incomplete understanding of its cost-effectiveness. AF ablation procedures involve …

Objectives: We sought to compare the cost-effectiveness of left atrial catheter ablation
(LACA), amiodarone, and rate control therapy in the management of atrial fibrillation (AF) …

Introduction Research evidence has shown that catheter ablation is a safe and superior
treatment for atrial fibrillation (AF) compared to medical therapy, but real‐world practice has …

Atrial fibrillation (AF) is a common and frequently disabling chronic condition associated with
significant patient morbidity and affecting an increasing stratum of our ageing society. Direct …

Background: Atrial Fibrillation is the most common cardiac arrhythmia. It increases the risk of
thromboembolic events and many atrial fibrillation patients suffer quality of life impairment …

Introduction: There is emerging evidence for clinical superiority of catheter ablation over rate
and rhythm control strategies in paroxysmal atrial fibrillation (PAF). The objective of this …

Atrial fibrillation (AF) is one of the most common cardiac conditions treated in primary care
and specialty cardiology settings, and is associated with considerable morbidity, mortality …

Randomised evidence supports an early rhythm control strategy as treatment for AF, and
catheter ablation outperforms medical therapy in terms of effectiveness when studied as first …